InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
3
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by LYNCH DANIEL, Director. Director active across 4 companies, notably SpringWorks Therapeutics, Inc.. Cumulatively, 17 reports have been logged. Split: 0 buy · 3 sells. Total volume traded: €6.2m. Activity tracked since 20 May 2021. The latest transaction was filed on 14 May 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations17 total
10,060 shares0Common StockSEC:0001104659-25-049662:0
44,018 shares@ US$60.138741.2% of flowCommon StockSEC:0001104659-25-016614:0
400 shares@ US$60.000.4% of flowCommon StockSEC:0001104659-25-015215:0
69,766 shares@ US$53.228758.4% of flowCommon StockSEC:0001104659-25-012364:0
4,095 shares0Common StockSEC:0001104659-24-062992:0
8,400 shares0Common StockSEC:0001562180-23-005219:0
4,648 shares0Common StockSEC:0001104659-23-064648:0
7,200 shares0Common StockSEC:0001562180-22-004992:0
4,818 shares0Common StockSEC:0001104659-22-063508:0
00Common StockSEC:0001628280-21-023649:0
00Common StockSEC:0001628280-21-023649
2,803 shares0Common StockSEC:0001628280-21-023471:0
2,803 shares0Common StockSEC:0001628280-21-023471
4,353 shares0Common StockSEC:0001562180-21-004349
4,353 shares0Common StockSEC:0001562180-21-004349:0
1,106 shares0Common StockSEC:0001104659-21-070515
1,106 shares0Common StockSEC:0001104659-21-070515:0
17 of 17 declarations
About LYNCH DANIEL
Daniel Lynch is a Board Member at SpringWorks Therapeutics, Inc. and bluebird bio, Inc. He plays a key role in the governance of these companies, bringing his expertise in management and strategy. His involvement in the boards allows him to contribute to strategic decision-making and guide the companies toward a sustainable future.
